Improv + ERP Therapy for OCD

ST
Overseen ByStudy Team
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new group therapy that combines ERP (exposure and response prevention) with improv exercises to help adults with obsessive-compulsive disorder (OCD). The researchers aim to determine if adding improv activities can enhance the effectiveness of traditional ERP therapy in managing OCD symptoms. Participants will attend weekly 90-minute sessions for 12 weeks, with homework and questionnaires to complete throughout. Individuals diagnosed with OCD who can participate in English-speaking group sessions might be a good fit. As an unphased trial, this study offers a unique opportunity to explore innovative therapy methods that could enhance the treatment experience.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this therapy is safe for adults with OCD?

Research has shown that exposure and response prevention (ERP) therapy safely treats obsessive-compulsive disorder (OCD). In one study, 64% of people with OCD experienced positive results from doing ERP therapy at home, indicating that many find ERP to be a good option.

Adding improv therapy to ERP is a new approach under testing. It aims to make therapy more engaging and effective. A small study found that improv helped reduce OCD symptoms, as well as depression and anxiety, and boosted overall well-being.

No reports of serious side effects have emerged from combining ERP with improv, suggesting it is safe for most people. However, since this therapy combination is new, more research is needed to confirm these findings.12345

Why are researchers excited about this trial?

Researchers are excited about ERP Plus Improv Group Therapy for OCD because it combines traditional Exposure and Response Prevention (ERP) with improv exercises, potentially enhancing treatment. While most OCD treatments like ERP alone focus on confronting fears and preventing compulsive responses, adding improv might increase engagement and creativity in therapy, helping patients adapt more flexibly. This novel approach could make therapy sessions more dynamic and enjoyable, potentially improving outcomes by encouraging patients to explore new ways of thinking and responding to their OCD symptoms.

What evidence suggests that ERP Plus Improv Group Therapy could be effective for OCD?

Research has shown that exposure and response prevention (ERP) effectively treats obsessive-compulsive disorder (OCD) and is often the first choice for managing it. One study with 11 OCD patients found that 64% responded well to doing ERP at home. In this trial, participants will try a new method that combines ERP with improv group therapy to enhance participation and results. Although using improv is new, ERP's strong track record suggests it could help reduce OCD symptoms.12346

Who Is on the Research Team?

Carolyn Rodriguez | Stanford Medicine

Carolyn Rodriguez, MD, PhD

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

This trial is for adults over 18 who can speak and understand English and have been diagnosed with Obsessive-Compulsive Disorder (OCD). It's not suitable for individuals currently having suicidal thoughts or those with medical or psychiatric conditions that could affect their participation.

Inclusion Criteria

Ability to speak and understand English
I have been diagnosed with obsessive-compulsive disorder.

Exclusion Criteria

Current active suicidality
Medical or psychiatric illness that could interfere with study participation

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants attend 90-minute ERP + improv group therapy sessions for 12 consecutive weeks, complete homework, answer questions, and complete questionnaires.

12 weeks
12 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • ERP Plus Improv Group Therapy
Trial Overview The study is testing a new group therapy method that combines Exposure Response Prevention (ERP) with improvisational group psychotherapy to see if it helps people with OCD.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: ERP combined with Improv Group TherapyExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

Published Research Related to This Trial

A systematic review of 19 clinical trials involving 587 patients found that optical treatments, particularly photodynamic therapy (PDT), can significantly improve inflammatory acne in the short term, with improvements of up to 68%.
While optical treatments show promise, they are not considered first-line therapies for acne vulgaris, and patients should be informed about potential side effects such as pain and hyperpigmentation, especially with treatments involving aminolevulinic acid (ALA) or methyl-aminolevulinic acid (MAL).
Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris.Haedersdal, M., Togsverd-Bo, K., Wulf, HC.[2018]
About 50% of surveyed physicians have used patient-delivered therapy (PDT) for nonviral STIs, recognizing its benefits in preventing the spread of infections and re-infection in patients, but only 6% use it frequently.
Despite acknowledging the advantages of PDT, many physicians expressed concerns about practical barriers, such as ensuring medication delivery to partners and potential liability issues, which may hinder its wider adoption.
Physicians' opinions on partner management for nonviral sexually transmitted infections.Niccolai, LM., Winston, DM.[2015]
In a study involving 11 patients with obsessive-compulsive disorder (OCD), 64% showed a positive response to home-based exposure and response prevention therapy after 24 sessions.
Of those treated, 36% experienced lasting improvements in their OCD symptoms, suggesting that this approach can be effective in real-world settings.
Home-based behavior therapy for obsessive-compulsive disorder: a case series with data.Rosqvist, J., Egan, D., Manzo, P., et al.[2019]

Citations

ERP Plus Improv Group Therapy for OCD (IMPROVE Study)The goal of this study is to pilot test a novel group therapy intervention for adults with OCD. Detailed Description. The intervention will incorporate exposure ...
ERP Plus Improv Group Therapy for OCD (IMPROVE Study)The goal of this study is to pilot test a novel group therapy intervention for adults with OCD.
Improv + ERP Therapy for OCD · Info for ParticipantsIn a study involving 11 patients with obsessive-compulsive disorder (OCD), 64% showed a positive response to home-based exposure and response prevention therapy ...
Exposure and response prevention for obsessive-compulsive ...In this review, we will describe the theoretical underpinnings and elements of ERP, examine the evidence for its effectiveness, and discuss new directions for ...
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40215475/
Exposure and Response Prevention in OCD: A Framework ...Exposure and response prevention (ERP) constitutes the first-line treatment for obsessive-compulsive disorder (OCD).
Improv intervention for Obsessive-Compulsive SymptomsThe Friedman test results showed statistically significant decreases in OCD, depression, and anxiety; and an increase in the well-being scores of the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security